Clinical Trial Update: A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating the efficacy and safety of ZL-1109 in Chinese participants with active Thyroid Eye Disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• ZL-1109

Snippet

Sponsor: Zai Lab (Shanghai) Co., Ltd. | Conditions: Thyroid Eye Disease (TED) | Phase 3 | Status: RECRUITING